Prevention of colorectal cancer by colonoscopy requires an effective and safe insertion technique, a high level of detection of pre-cancerous lesions, and skillful use of curative endoscopic resection techniques. Lesion detection, characterization, use of appropriate resection methods, prediction of cancer at colonoscopy, and management of malignant polyps all depend on an accurate and complete understanding of an extensive vocabulary describing the histology and morphology of neoplastic colorectal lesions. Incomplete understanding of vocabulary terms can lead to management errors. We provide a colonoscopist's perspective on the vocabulary of colorectal neoplasia and discuss the interaction of specific terms with management decisions.
Prevention of colorectal cancer by colonoscopy requires an effective and safe insertion technique, a high level of detection of pre-cancerous lesions, and skillful use of curative endoscopic resection techniques. Lesion detection, characterization, use of appropriate resection methods, prediction of cancer at colonoscopy, and management of malignant polyps all depend on an accurate and complete understanding of an extensive vocabulary describing the histology and morphology of neoplastic colorectal lesions. Incomplete understanding of vocabulary terms can lead to management errors. We provide a colonoscopist's perspective on the vocabulary of colorectal neoplasia and discuss the interaction of specific terms with management decisions.
Nearly 60% of the eligible U.S. population report being up to date with colorectal cancer screening, with colonoscopy the most commonly used screening test. 1 Many gastroenterologists spend more time performing colonoscopy than any other professional activity. One would expect gastroenterologists to be expert in all aspects of the vocabulary of colorectal neoplasia, including histologic and morphologic classifications of polypoid and flat lesions.
However, speaking to groups of gastroenterologists and other endoscopists, the responses to fundamental questions about colorectal neoplasia are often surprising. For example: How reliable is a pathologist's designation of dysplasia grade in a conventional adenoma? Why is the term "dysplastic adenoma" redundant? Why should the term "intramucosal adenocarcinoma" not be used in pathology reports? What is the histologic difference between a hyperplastic polyp (HP) and a sessile serrated polyp/adenoma? What are the implications of granular versus non-granular morphology in a lateralspreading tumor? What is the histologic definition of colon cancer?
The answers to these and similar questions provide colonoscopists with critical insights into the limitations of pathology, the proper responses to pathologic interpretations of colon polyps, and in many cases to optimal endoscopic, clinical, or surgical management. A detailed understanding of the implications of both endoscopic appearances and histology is critical in guiding the colonoscopist. The modern expert colonoscopist is able to use electronic chromoendoscopy techniques and established classification schemes to predict lesion histology. Thus, an expert colonoscopist is able to differentiate between a serrated and adenomatous polyp, and between a deeply invasive cancer versus superficial colorectal neoplasia. This review provides a clinically oriented framework to the vocabulary surrounding the main classes of colorectal lesions, particularly the conventional adenomas and serrated lesions. The implications of this vocabulary on management and follow-up are stressed, including how the endoscopic assessment of histology and morphology direct the selection of specific therapies such as EMR, endoscopic submucosal dissection (ESD), and surgical resection.
What are EMR and ESD?
EMR refers to submucosal fluid injection followed by en bloc or piecemeal snare resection. EMR is easier to perform than ESD, requires less training, has a much lower risk of perforation, and a lower need for hospitalization after resection. EMR may be technically quite difficult when lesions are very large, very flat, in a technically challenging position, or when they are accompanied by submucosal fibrosis. Both EMR and ESD have substantial risks of delayed post-polypectomy hemorrhage. For these reasons, many patients with colorectal lesions that are benign and removable by EMR are sent directly to surgery in the United States and Europe, 2,3 even though surgery results in higher costs, morbidity, and mortality than EMR. [4] [5] [6] ESD was developed in Japan to treat early gastric cancer. ESD has been extended to the colon, where it has been used successfully by Japanese experts [7] [8] [9] and increasingly by western experts. [10] [11] [12] The technique involves submucosal injection, but ESD does not use snare resection. Specialized endoscopic needle-like knives are used to create a circumferential incision through the mucosa around the lesion, followed by dissection through the submucosa under the lesion. The goal of ESD is en bloc resection in all cases, and ESD is much more likely than EMR to achieve this result. 13 The en bloc tissue specimen is pinned before fixation to provide proper orientation for pathologic assessment of the deep and lateral resection margins. Whether ESD should be used more extensively in the West is controversial. Given the advantages of EMR relative to ESD noted above, which patients and how many patients really benefit from ESD compared with EMR is a critical issue that is discussed in detail below.
The colonoscopist's vocabulary of colorectal cancer
Because the colon has no mucosal lymphatics, colon cancer is defined in western countries as invasion of dysplastic cells into the submucosa. It follows that any neoplastic lesion that is confined to the mucosa, including epithelium, lamina propria, and muscularis mucosa, must be considered pre-cancerous or non-invasive, irrespective of its dysplastic or cytologic appearance, and is best named as low-or high-grade dysplasia. Some pathologists still use terms such as "carcinoma in situ" and "intramucosal adenocarcinoma" to describe lesions involving severe dysplastic changes confined to the epithelium or lamina propria, respectively. However, these terms are often misinterpreted by patients, referring physicians, and sometimes by colonoscopists, as cancer because they include the word "carcinoma." This confusion can result in unnecessary surgery or excessive follow-up for a lesion that is benign by definition. Such lesions have no lymph node or distant metastatic potential because they lack submucosal invasion, and complete endoscopic resection is uniformly curative. 14 Current U.S. National Comprehensive Cancer Network guidelines specifically state, "A malignant polyp is defined as one with cancer invading through the muscularis mucosa and into the submucosa (T1). Tis is not considered a 'malignant polyp'" (https:// www.nccn.org/professionals/physician_gls/pdf/colon.pdf). We recommend that colonoscopists meet with their pathologists to reach consensus regarding optimal terminology, and that colonoscopists take the position that pathologists report "high-grade dysplasia" and not use the terms "intramucosal carcinoma" or "carcinoma in situ," in order to reduce the potential for clinical management errors (Table 1) . Western colonoscopists may also be confused because Japanese pathologists and gastroenterologists commonly use the term "intramucosal carcinoma" and count it as cancer. This difference is related to cultural and economic issues, whereas no clinical difference is present, ie, endoscopy is still considered completely adequate treatment for such lesions in Japan. We recommend that, in western countries, the terms "carcinoma in situ" and "intramucosal carcinoma" be abandoned because they may lead to incorrect patient management. Terminology should serve patients and physicians by optimizing rather than confusing management, and hence the term cancer is reserved (in the colorectum) in western countries exclusively for submucosal invasion.
What is superficial versus deep submucosal cancer?
When submucosal cancer is present in a pedunculated polyp, endoscopy is usually regarded as an adequate treatment when 3 histologic factors, namely cancer at the resection margin, lympho-vascular invasion, and poor differentiation, are absent. 13 When invasive cancer is present in a flat (ie, non-polypoid) or sessile lesion, the depth of invasion below the muscularis mucosa (MM) should be measured by the pathologist when technically feasible. If the depth is <1000 mm, the submucosal cancer is classified as "superficial." If the depth of invasion is >1000 mm, the cancer demonstrates "deep submucosal invasion." There are elements of subjectivity with this measurement because the MM layer may be disrupted or not visible. Reliable measurement of the depth of invasion is generally considered to require en bloc resection of the lesion by conventional snare techniques for smaller lesions and either en bloc EMR or ESD for lesions >10 to 20 mm. Pinning the lesion to allow proper orientation for histologic sectioning is important. 12, 13 When a superficial submucosal cancer does not present lymphovascular invasion or poor differentiation after an en bloc resection, endoscopic treatment may be considered as adequate because of a very low risk of lymph node metastasis. In contrast, the risk of lymph node metastasis increases substantially when deep submucosal invasion is present.
When deep submucosal invasion is predicted by endoscopic features, 15 it is preferable to avoid endoscopic resection and proceed to surgery. This prevents the risk of endoscopic adverse events, and endoscopic resection followed by pathology demonstrating deep submucosal invasion will result in surgery in any case. If superficial invasion is identified after piecemeal snare resection of a flat or sessile lesion, surgical resection is often still considered because of the risk of understaging a potentially deeply invasive cancer, especially if adequate orientation of the specimen by the pathologist is not feasible. This difference highlights the benefit of en bloc resection. With en bloc resection of a sessile or flat lesion and proper specimen orientation, the patient with superficial invasion (and lacking other adverse histologic features) has the option of relying on endoscopic resection alone, because the risk of lymph node metastasis is very low (although not 0). In the West, many patients in this situation, especially if they are young (eg, <60 years old) and healthy, will select surgical resection even when all histologic criteria associated with submucosal invasion are favorable, because the risk of metastasis with favorable criteria is very low but not 0. Again, when the same lesion has been treated by piecemeal snare resection, confidence in whether adequate treatment has been provided by endoscopy is undermined. Endoscopic predictors of deep (>1000 mm) submucosal invasion in flat and sessile lesions are described in the type 3 category of the Narrow-band Imaging International Colorectal Endoscopic (NICE) classification 15, 16 (Table 2) . Identification of NICE type 3 features in a flat or sessile lesion is generally an indication for surgical resection (Fig. 1 ). If surgery is planned, a biopsy sample from the NICE type 3 area can be examined to confirm invasive cancer. In Japan, reliance on NICE alone to predict cancer endoscopically is considered inadequate, because the magnifying endoscopes widely used in Japan can identify features that extend the predictions achievable with the high-definition instruments commonly in use in North America and Europe. These features are summarized in the Japan NBI Expert Team (JNET) classification for magnifying colonoscopy. 17 Widespread use of the JNET classification in the West, where magnifying colonoscopes are not widely used, is not anticipated in the near future. Unfortunately, no reliable endoscopic features differentiate superficial submucosal invasion from high-grade dysplasia. 15, 16 However, some endoscopic morphologic features are associated with a higher risk of submucosal invasion, namely non-granular lateral-spreading tumors (LSTs), particularly those with a focal depressed component, and to a lesser extent large mixed-type granular lesions (granular lesions with nodules). 18 The term "LST" refers to a flat or sessile lesion with a diameter of at least 1 cm. 19 The morphology of LSTs and the association with invasive cancer are discussed in more detail below.
As noted above, patients who will benefit from ESD rather than piecemeal EMR are those with superficial submucosal invasion that cannot be removed en bloc by EMR. In European series, this group is about 2% to 3% of patients referred for resection of large colorectal lesions. [10] [11] [12] In Japanese series, 7% to 10% of colorectal lesions subjected to ESD have superficial invasion, reflecting better patient selection for ESD (higher fraction of non-granular LSTs). [7] [8] [9] Non-granular LSTs >20 mm in size (en bloc excision by EMR is generally limited to lesions 20 mm) with focal depression and lacking NICE type 3 features are the best candidates for ESD in the colorectum, as they have the highest rate of superficial submucosal invasion. EMR can still be used to treat these lesions, but the patient may be referred for surgery if there is submucosal invasion, regardless of the depth of invasion.
The vocabulary of conventional adenomas
The main histologic classes of pre-cancerous colorectal neoplasia are the conventional adenomas and the serrated class lesions (Fig. 2) . Pathologists are generally accurate in assigning lesions to the conventional adenomas versus the serrated class. 20 Experienced colonoscopists are also effective at predicting the histologic class of specific lesions using criteria such as NICE ( Table 2) .
Pathologists subclassify conventional adenomas according to the dysplasia grade (low versus high is the proper designation; mild, moderate, severe are outdated), and tubular versus villous elements. Although the placement of lesions into the conventional adenoma category by the pathologist is reliable, the subclassifications are unreliable. 20 Stated differently, they are subject to substantial interobserver variation (Table 3) , and this is particularly true in their application to polyps <1 cm in size. 21 This size group is of particular relevance because polyps 1 cm in size are considered advanced lesions based on their size alone, whereas lesions <1 cm in size are not advanced unless they have either high-grade dysplasia or villous elements. The overwhelming majority of adenomas are tubular, that is, they contain 75% tubular elements. Using identical definitions, pathologists vary by up to 6-fold in the frequency with which they call polyps tubulovillous. 21 Problems with interpretations of dysplasia grade are even greater because there is no clear consensus on the definition of high-grade histology. 21 Pathologists who read high percentages of lesions with high-grade dysplasia are typically using cytologic criteria in addition to morphologic criteria. Any reading of high-grade dysplasia in a conventional adenoma <1 cm in size is suspect and may not withstand review by another or an expert gastrointestinal pathologist. 21 Currently, there are no reliable endoscopic criteria to differentiate dysplasia grade or villosity in a conventional adenoma, so colonoscopists must rely on the interpretation by pathologists. However, the expected prevalence of villous elements and high-grade dysplasia in 6 to 9 mm lesions is quite low, and even lower in conventional adenomas 5 mm in size. 22 The unreliability of pathologic interpretation of dysplasia grade and villosity is such that the British Society of Gastroenterology ignores these elements in their postpolypectomy surveillance guideline. 23 Although diagnoses of dysplasia grade and villosity are subject to marked interobserver variation between pathologists, these factors are included as determinants of surveillance intervals in clinical guidelines. As noted above, the appropriateness of using these factors as surveillance determinants is controversial.
Using the NICE classification, expert colonoscopists can predict adenomatous versus serrated class histology with an accuracy similar to pathologists. This approach forms the basis of new paradigms for diminutive polyp management, including the "resect and discard" scheme and leaving distal colon diminutive hyperplasticappearing polyps in place without resection. 24 Predicting adenomatous histology endoscopically is also important to the therapeutic colonoscopist. Specifically, the adenomas are a more challenging group of lesions to resect than the serrated lesions (see below). The adenomas can become very large (nearly circumferential and extending longitudinally over multiple haustral folds). Non-granular LSTs and the depressed class of lesions are almost entirely adenomas. Adenomas are much more likely to have submucosal fibrosis than serrated lesions, and submucosal fibrosis is the bane of EMR. Serrated lesions present their own set of obstacles to endoscopic resection, 25 but they are usually easily overcome.
The vocabulary of serrated lesions
The "serrated class" includes 3 distinct groups of lesions: HPs, sessile serrated polyp (SSPs) (also called sessile serrated adenoma [SSAs]), and traditional serrated adenomas (TSAs) (Fig. 2) . 26 TSAs are rare by comparison with the other 2 serrated class subtypes. TSAs are located mostly in the left side of the colon, are usually sessile, and are the only group of serrated class lesions that is consistently dysplastic. 27 Because they grow in a villous pattern and are dysplastic, TSAs may be interpreted by pathologists as tubulovillous adenomas. 27 This error appears to be made so consistently by some pathologists that colonoscopists often anecdotally report never seeing TSA on a pathology report. Because TSAs are rare, we focus here on the HPs and SSPs/SSAs, both of which are quite common.
As stated earlier, both pathologists and colonoscopists accurately place polyps into the conventional adenoma versus serrated class (with the exception of TSAs). Unlike the conventional adenomas and TSAs, all of the HPs and the overwhelming majority of SSPs are non-dysplastic. 27 SSP is synonymous with SSA, 26 but we prefer "sessile serrated polyp" in conversation and on pathology reports. This preference is because clinicians interpret the word "adenoma" to signify dysplasia (as noted above, all conventional adenomas are dysplastic). Thus, clinicians often believe that a "sessile serrated adenoma" must be dysplastic. Since most of these lesions are not dysplastic, we feel "SSP" causes less confusion for clinicians. Despite this preference, we acknowledge that neither "SSP" nor "SSA" is ideal from the perspective that many of these lesions are flat and not polyps (both terms contain the word "sessile"), and "SSP" could compound this confusion by including the word "polyp." Regardless of which term (SSP or SSA) is used, clinicians must understand that (1) SSP and SSA are synonyms, (2) these lesions can be either sessile or flat, and (3) these lesions are usually not dysplastic. To further acknowledge that SSP and SSA are synonyms, we refer to the lesions here by the commonly accepted acronym "SSA/P." 27 The histologic differentiation of an HP from an SSA/P rests primarily on the shape of crypts. 27 SSA/Ps have crypts that are dilated, distorted, or demonstrate lateral growth, whereas the crypts of hyperplastic polyps are straight. Unfortunately, no definition of the extent to which the crypts should be distorted has been validated as having clinical significance in distinguishing a group of polyps (SSA/Ps) with malignant potential and distinct behavior from HPs. Further, different histologic criteria for SSA/P are in use. For example, the World Health Organization recommends that 3 abnormal crypts constitute a diagnosis of SSA/P, 26 whereas a National Institutes of Health consensus panel recommended that one unequivocally abnormal crypt is diagnostic of SSA/ P, 27 and the Japanese Pathology Society recommends that 10% of the crypt be affected to diagnose SSA/P. 28 When the number of crypts affected by distortion is small, there is substantial interobserver variation in differentiating HP from SSP. 29 Although the overwhelming majority of SSA/Ps have no cytologic dysplasia (Table 3) , a small percentage contain a region that looks like a conventional adenoma (Fig. 3) . In decades past, this lesion was designated a "mixed hyperplastic-adenomatous polyp," which was perfectly logical because these polyps contain regions that endoscopically and histologically correspond to the serrated class and the conventional adenoma class, respectively. The dysplastic area in an SSA/P is the portion with histologic features of a conventional adenoma and which endoscopically has NICE type 2 features, whereas the remainder of the polyp is NICE type 1 30 (Fig. 4 ). Any dysplasia (low grade or high grade) in an SSA/P constitutes a more-advanced lesion than an SSA/P without cytologic dysplasia, 27 and one that could progress rapidly to cancer. 31 The area of dysplasia often demonstrates microsatellite instability in microdissection studies. 32 Endoscopic criteria for differentiation of HP from SSA/ P have been proposed and validated in the Workgroup serrAted PolypS and Polyposis (WASP) classification 33 ( Table 4 and Fig. 5 ), but their accuracy in differentiating HP from SSA/P in diminutive size lesions is not established. Given the substantial interobserver variation in distinguishing SSA/P from HP pathologically, and because the prevalence of SSA/P increases with lesion size, any proximal colon serrated class lesion 1 cm in size and interpreted pathologically as hyperplastic can be reasonably treated for surveillance purposes as an SSA/P. 34 This approach is particularly appropriate if the lesion has endoscopic features of SSA/P. 33 Diminutive NICE type 1 lesions in the rectosigmoid are almost all hyperplastic, 35 which is the rationale for leaving them in place. 24 For the therapeutic colonoscopist, the key feature of SSA/Ps is their endoscopically indistinct edges, which often leads to incomplete resection using traditional polypectomy techniques (snaring without submucosal injection). This problem is easily overcome by submucosal injection of a contrast agent and use of a Note the smooth hard appearance of the residual lesion, which leads to the "non-granular" terminology. Non-granular LSTs are more likely to have advanced neoplasia, including invasive cancer, and more likely to be technically challenging to remove by EMR because of submucosal fibrosis. E, A small (13 mm) non-granular LST with a smooth hard appearance and some central depression (black þ mark). The arrows point to an edge that is scarred from a previous partial resection. The lesion was removed by en bloc EMR and demonstrated high-grade dysplasia on pathology. F, A large non-granular LST in the ascending colon. The lesion demonstrated high-grade dysplasia and a tiny focus of invasive adenocarcinoma. high-definition colonoscope, which in combination allow easy tracking of the perimeter during resection. 36, 37 The size threshold for performing submucosal injection in SSA/Ps should be 10 to 15 mm. 38 Piecemeal cold snare excision of non-dysplastic SSA/Ps, which is facilitated by submucosal injection, is an evolving area of interest. Cold resection largely prevents the risks of EMR. ESD is unnecessary for serrated lesions, because they almost universally lack invasive disease unless endoscopic features of dysplasia, large nodules, or depressed areas are present.
The vocabulary of polyp morphology
The morphology of colon polyps is of great importance to colonoscopists, and to a lesser degree to pathologists. The Paris classification provides a useful framework for discussing polyp shape and emphasizes the subtle nature of flat lesions (Fig. 6) . Training in the Paris classification should be included in all endoscopic training as an enhancement to detection. Interobserver agreement in assigning lesions to Paris classification categories is moderately good at best, 39 but still the classification provides a useful clinical framework for discussing morphology.
Paris type 1 lesions are polyps. Paris type 2 lesions include flat (types 2a and 2b) and depressed (2c and its variants) lesions. High-detecting colonoscopists find such large numbers of diminutive flat adenomas that 2a and 1s lesions are present in approximately equal numbers. 40 Paris 2c depressed lesions are both rare and enormously important because of their very high prevalence of highgrade dysplasia and cancer relative to all other morphologies. 41 The prevalence of cancer in both Paris type 1 and 2a lesions is extremely low, whereas the prevalence of high-grade dysplasia and cancer in 2c lesions can reach 50%. 38 Depression is characterized by a sharp drop off from the elevated to depressed portions, and the total area of the depression is substantial. Much more common is the "2a pseudodepression," which has sloping edges and usually occupies a much smaller surface area, and does not extend down to or below the level of the normal mucosa adjacent to the lesion. Unlike true depressions, pseudodepressions have no importance as a predictor of advanced histology.
If a depressed lesion presents features suggestive of advanced cancer, such as ulceration or an amorphous vascular pattern, a biopsy specimen should be taken followed by surgery. On the other hand, if the surface pattern is preserved, en bloc resection should be considered in order to provide adequate staging and treatment for a possible superficial submucosal cancer.
Flat lesions extending 1 cm in diameter are designated in the Paris classification as LSTs, and they may have a sessile component (mixed LST). They are sometimes now called lateral-spreading lesions as the term "tumor" can be misinterpreted to mean invasive disease, and in years past they were called "carpet polyps." LSTs are further characterized as granular, with a lumpy, bumpy surface ( Fig. 7) or "non-granular," with a smooth surface. Chromoendoscopy enhances the surface features and can clarify granular versus non-granular morphology. The significance of granular and non-granular is demonstrated in Table 5 . Homogeneous granular lesions (like the surface of a bowl of rice crispies) have an extremely low prevalence of invasive disease at <1%. These lesions grow laterally, sometimes for very long periods of time, and a risk of invasive disease is acquired when a nodule develops (granular LST mixed nodular type). Nodules in granular LSTs are associated with an approximately 5% risk of invasive cancer 18 (Table 5 ). Non-granular lesions can be difficult to resect by EMR because they have a high prevalence of submucosal fibrosis and often a low mucosal profile that may defy snare capture. The prevalence of cancer is higher in non-granular LSTs, particularly those with depression. Again, a non-granular LST with depression that lacks NICE type 3 features is the best clinical indication for ESD over EMR.
The terms granular and non-granular LST are used for LSTs of the conventional adenoma class. This classification has no proven benefit in describing large SSA/Ps, which have different surface features from adenomas. Large SSA/Ps are flat or sessile in shape, almost never have significant fibrosis in the submucosa, and rarely contain cancer Putting it all together Table 6 summarizes clinically relevant information regarding pre-cancerous colorectal polyps. An effective colonoscopic withdrawal technique has 3 basic components, including continuous effort to examine the proximal sides of haustral folds, achieving adequate distention, and cleaning the mucosal surfaces. 43 However, the mechanical aspects of the withdrawal technique must be combined with complete understanding of the spectrum of precancerous colorectal lesions. This understanding guides the approach and eyes of the colonoscopist. Thus, a full understanding of the Paris classification ensures awareness of the large pool of subtle lesions. Table 6 shows that the distribution of the Paris type 2 lesions, whether conventional or serrated, is skewed toward the proximal colon. The skewed distribution of flat and depressed lesions toward the proximal colon may partly account for why colonoscopy fails to protect against proximal colon cancer as well as distal cancers. 44, 45 Detailed understanding of the disease spectrum and meticulous technique lead to high adenoma detection rates. In the resection phase, understanding the implications of lesion morphology is essential to correct decision making. For example, SSA/Ps are less effectively removed by standard snaring techniques because of their indiscrete edges. At a relatively low size threshold, EMR with a contrast agent permits effective SSA/P resection. Further, SSA/Ps almost never have significant submucosal fibrosis, making EMR straightforward. If an LST is recognized endoscopically as a conventional adenoma, it is further classified as granular versus non-granular. Granular lesions have little or no submucosal fibrosis, and again, EMR will be relatively easy. Non-granular tumors have an increased risk of both cancer and submucosal fibrosis, and the knowledgeable colonoscopist anticipates the need for specific methods to counter submucosal fibrosis, (eg, avulsion 46 ). Non-granular lesions demonstrating true depression have a higher risk for cancer, and ESD may be warranted if available. For both granular and non-granular tumors, the surface of the lesion should be carefully evaluated for NICE type 3 features, which should lead to endoscopic biopsy and then surgery.
Understanding clinically relevant histology guides post-resection management. Knowing that "intramucosal adenocarcinoma" and "carcinoma in situ" are not actually cancer, the colonoscopist should recommend to the pathologist that the term high-grade dysplasia be substituted. High-grade dysplasia is a benign lesion and does not warrant overreaction. Thus, a completely resected lesion with high-grade dysplasia has been cured. The informed colonoscopist takes pathologic readings of "villous" and "high-grade dysplasia" with a grain of salt, particularly in lesions <10 mm, based on high interobserver variation between pathologists.
Colonoscopists prefer the term "sessile serrated polyp," but understand that SSP and SSA are synonymous terms. Colonoscopists want SSA/Ps to be designated by pathologists as without or with cytologic dysplasia. SSA/Ps with cytologic dysplasia are often recognized as such endoscopically because of their mixed NICE type 1/NICE type 2 features. The SSA/P with cytologic dysplasia is recognized as a more advanced lesion that must be completely resected endoscopically.
To conclude, accurate and thorough understanding of the vocabulary of polyp histology and morphology classification are fundamental to the modern colonoscopist's approach to detection, resection, and post-resection management.
